UBS AM’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$153M Buy
2,933,988
+156,948
+6% +$8.17M 0.03% 450
2025
Q1
$118M Buy
2,777,040
+164,263
+6% +$7M 0.03% 495
2024
Q4
$79.8M Sell
2,612,777
-731,260
-22% -$22.3M 0.02% 563
2024
Q3
$76.7M Buy
3,344,037
+110,993
+3% +$2.55M 0.02% 580
2024
Q2
$93.4M Buy
3,233,044
+2,331,011
+258% +$67.3M 0.03% 477
2024
Q1
$18.6M Buy
902,033
+265,941
+42% +$5.49M 0.01% 807
2023
Q4
$17.2M Buy
636,092
+49,643
+8% +$1.34M 0.01% 804
2023
Q3
$17.4M Buy
586,449
+298,172
+103% +$8.84M 0.01% 792
2023
Q2
$6.76M Hold
288,277
﹤0.01% 1107
2023
Q1
$6.76M Buy
288,277
+3,792
+1% +$88.9K ﹤0.01% 1107
2022
Q4
$7.74M Buy
284,485
+146,794
+107% +$3.99M ﹤0.01% 1027
2022
Q3
$7.41M Sell
137,691
-22,199
-14% -$1.19M ﹤0.01% 1061
2022
Q2
$6.45M Sell
159,890
-81,259
-34% -$3.28M ﹤0.01% 1120
2022
Q1
$16M Sell
241,149
-42,884
-15% -$2.84M 0.01% 909
2021
Q4
$28.4M Buy
284,033
+37,780
+15% +$3.78M 0.01% 811
2021
Q3
$30.8M Buy
246,253
+139,023
+130% +$17.4M 0.01% 755
2021
Q2
$13.3M Buy
107,230
+5,692
+6% +$707K 0.01% 1014
2021
Q1
$15.5M Buy
101,538
+561
+0.6% +$85.6K 0.01% 937
2020
Q4
$13M Buy
100,977
+36,796
+57% +$4.74M 0.01% 963
2020
Q3
$7.17M Buy
64,181
+402
+0.6% +$44.9K ﹤0.01% 1035
2020
Q2
$5.17M Buy
63,779
+13,673
+27% +$1.11M ﹤0.01% 1105
2020
Q1
$3.49M Buy
50,106
+11,757
+31% +$818K ﹤0.01% 1197
2019
Q4
$3M Sell
38,349
-4,902
-11% -$383K ﹤0.01% 1431
2019
Q3
$2.76M Buy
43,251
+19,718
+84% +$1.26M ﹤0.01% 1465
2019
Q2
$2.03M Buy
+23,533
New +$2.03M ﹤0.01% 1583